nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLCO1A2—Prednisolone—psoriatic arthritis	0.0958	0.113	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—psoriatic arthritis	0.0904	0.107	CbGbCtD
Nelfinavir—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0565	0.0669	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—psoriatic arthritis	0.0454	0.0538	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—psoriatic arthritis	0.0428	0.0507	CbGbCtD
Nelfinavir—ABCG2—Dexamethasone—psoriatic arthritis	0.0423	0.0501	CbGbCtD
Nelfinavir—ABCB1—Methylprednisolone—psoriatic arthritis	0.0403	0.0478	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—psoriatic arthritis	0.034	0.0403	CbGbCtD
Nelfinavir—CYP3A7—Dexamethasone—psoriatic arthritis	0.0313	0.037	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0313	0.037	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—psoriatic arthritis	0.0303	0.0359	CbGbCtD
Nelfinavir—CYP2B6—Dexamethasone—psoriatic arthritis	0.0298	0.0353	CbGbCtD
Nelfinavir—ABCB1—Betamethasone—psoriatic arthritis	0.0262	0.0311	CbGbCtD
Nelfinavir—ABCB1—Prednisolone—psoriatic arthritis	0.0259	0.0307	CbGbCtD
Nelfinavir—ABCB1—Prednisone—psoriatic arthritis	0.0244	0.029	CbGbCtD
Nelfinavir—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0242	0.0286	CbGbCtD
Nelfinavir—CYP3A5—Dexamethasone—psoriatic arthritis	0.0234	0.0278	CbGbCtD
Nelfinavir—CYP2C19—Dexamethasone—psoriatic arthritis	0.0189	0.0224	CbGbCtD
Nelfinavir—CYP3A4—Triamcinolone—psoriatic arthritis	0.0183	0.0217	CbGbCtD
Nelfinavir—CYP2C9—Dexamethasone—psoriatic arthritis	0.0157	0.0186	CbGbCtD
Nelfinavir—CYP3A4—Betamethasone—psoriatic arthritis	0.0157	0.0186	CbGbCtD
Nelfinavir—CYP3A4—Prednisolone—psoriatic arthritis	0.0155	0.0184	CbGbCtD
Nelfinavir—ABCB1—Dexamethasone—psoriatic arthritis	0.0153	0.0181	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—psoriatic arthritis	0.0146	0.0173	CbGbCtD
Nelfinavir—CYP2D6—Dexamethasone—psoriatic arthritis	0.0144	0.017	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—psoriatic arthritis	0.0123	0.0145	CbGbCtD
Nelfinavir—CYP3A4—Dexamethasone—psoriatic arthritis	0.00914	0.0108	CbGbCtD
Nelfinavir—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000389	0.0025	CcSEcCtD
Nelfinavir—Neutropenia—Prednisone—psoriatic arthritis	0.000386	0.00247	CcSEcCtD
Nelfinavir—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000381	0.00244	CcSEcCtD
Nelfinavir—Haemoglobin—Betamethasone—psoriatic arthritis	0.000381	0.00244	CcSEcCtD
Nelfinavir—Haemorrhage—Betamethasone—psoriatic arthritis	0.000379	0.00243	CcSEcCtD
Nelfinavir—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000379	0.00243	CcSEcCtD
Nelfinavir—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000378	0.00243	CcSEcCtD
Nelfinavir—Mood swings—Methotrexate—psoriatic arthritis	0.000378	0.00242	CcSEcCtD
Nelfinavir—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000376	0.00242	CcSEcCtD
Nelfinavir—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000372	0.00239	CcSEcCtD
Nelfinavir—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000368	0.00236	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000367	0.00235	CcSEcCtD
Nelfinavir—Erythema—Triamcinolone—psoriatic arthritis	0.000364	0.00233	CcSEcCtD
Nelfinavir—Erythema—Methylprednisolone—psoriatic arthritis	0.000363	0.00233	CcSEcCtD
Nelfinavir—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000363	0.00233	CcSEcCtD
Nelfinavir—Malaise—Prednisolone—psoriatic arthritis	0.000357	0.00229	CcSEcCtD
Nelfinavir—Eye disorder—Dexamethasone—psoriatic arthritis	0.000354	0.00227	CcSEcCtD
Nelfinavir—Eye disorder—Betamethasone—psoriatic arthritis	0.000354	0.00227	CcSEcCtD
Nelfinavir—Back pain—Triamcinolone—psoriatic arthritis	0.000352	0.00226	CcSEcCtD
Nelfinavir—Angiopathy—Betamethasone—psoriatic arthritis	0.000344	0.00221	CcSEcCtD
Nelfinavir—Angiopathy—Dexamethasone—psoriatic arthritis	0.000344	0.00221	CcSEcCtD
Nelfinavir—Convulsion—Prednisolone—psoriatic arthritis	0.000343	0.0022	CcSEcCtD
Nelfinavir—Pancreatitis—Methotrexate—psoriatic arthritis	0.000338	0.00217	CcSEcCtD
Nelfinavir—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000337	0.00216	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000337	0.00216	CcSEcCtD
Nelfinavir—Discomfort—Prednisolone—psoriatic arthritis	0.000333	0.00213	CcSEcCtD
Nelfinavir—Haemoglobin—Prednisone—psoriatic arthritis	0.000332	0.00213	CcSEcCtD
Nelfinavir—Haemorrhage—Prednisone—psoriatic arthritis	0.00033	0.00212	CcSEcCtD
Nelfinavir—Erythema—Dexamethasone—psoriatic arthritis	0.00033	0.00212	CcSEcCtD
Nelfinavir—Erythema—Betamethasone—psoriatic arthritis	0.00033	0.00212	CcSEcCtD
Nelfinavir—Malaise—Triamcinolone—psoriatic arthritis	0.000328	0.0021	CcSEcCtD
Nelfinavir—Malaise—Methylprednisolone—psoriatic arthritis	0.000327	0.0021	CcSEcCtD
Nelfinavir—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000324	0.00208	CcSEcCtD
Nelfinavir—Oedema—Prednisolone—psoriatic arthritis	0.000323	0.00207	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—psoriatic arthritis	0.000322	0.00207	CcSEcCtD
Nelfinavir—Convulsion—Triamcinolone—psoriatic arthritis	0.000315	0.00202	CcSEcCtD
Nelfinavir—Convulsion—Methylprednisolone—psoriatic arthritis	0.000314	0.00202	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000312	0.002	CcSEcCtD
Nelfinavir—Myalgia—Triamcinolone—psoriatic arthritis	0.00031	0.00199	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—psoriatic arthritis	0.000309	0.00198	CcSEcCtD
Nelfinavir—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000309	0.00198	CcSEcCtD
Nelfinavir—Myalgia—Methylprednisolone—psoriatic arthritis	0.000309	0.00198	CcSEcCtD
Nelfinavir—Eye disorder—Prednisone—psoriatic arthritis	0.000308	0.00198	CcSEcCtD
Nelfinavir—Anxiety—Methylprednisolone—psoriatic arthritis	0.000308	0.00197	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000307	0.00197	CcSEcCtD
Nelfinavir—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000306	0.00196	CcSEcCtD
Nelfinavir—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000306	0.00196	CcSEcCtD
Nelfinavir—Discomfort—Triamcinolone—psoriatic arthritis	0.000306	0.00196	CcSEcCtD
Nelfinavir—Discomfort—Methylprednisolone—psoriatic arthritis	0.000305	0.00196	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—psoriatic arthritis	0.000299	0.00192	CcSEcCtD
Nelfinavir—Angiopathy—Prednisone—psoriatic arthritis	0.000299	0.00192	CcSEcCtD
Nelfinavir—Immune system disorder—Prednisone—psoriatic arthritis	0.000298	0.00191	CcSEcCtD
Nelfinavir—Malaise—Dexamethasone—psoriatic arthritis	0.000298	0.00191	CcSEcCtD
Nelfinavir—Malaise—Betamethasone—psoriatic arthritis	0.000298	0.00191	CcSEcCtD
Nelfinavir—Oedema—Triamcinolone—psoriatic arthritis	0.000297	0.0019	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—psoriatic arthritis	0.000295	0.00189	CcSEcCtD
Nelfinavir—Insomnia—Prednisolone—psoriatic arthritis	0.000292	0.00187	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000291	0.00186	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—psoriatic arthritis	0.00029	0.00186	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisolone—psoriatic arthritis	0.00029	0.00186	CcSEcCtD
Nelfinavir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000288	0.00185	CcSEcCtD
Nelfinavir—Erythema—Prednisone—psoriatic arthritis	0.000287	0.00184	CcSEcCtD
Nelfinavir—Malnutrition—Prednisone—psoriatic arthritis	0.000287	0.00184	CcSEcCtD
Nelfinavir—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000287	0.00184	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000286	0.00184	CcSEcCtD
Nelfinavir—Convulsion—Dexamethasone—psoriatic arthritis	0.000286	0.00183	CcSEcCtD
Nelfinavir—Convulsion—Betamethasone—psoriatic arthritis	0.000286	0.00183	CcSEcCtD
Nelfinavir—Myalgia—Betamethasone—psoriatic arthritis	0.000281	0.0018	CcSEcCtD
Nelfinavir—Myalgia—Dexamethasone—psoriatic arthritis	0.000281	0.0018	CcSEcCtD
Nelfinavir—Anxiety—Dexamethasone—psoriatic arthritis	0.00028	0.0018	CcSEcCtD
Nelfinavir—Anxiety—Betamethasone—psoriatic arthritis	0.00028	0.0018	CcSEcCtD
Nelfinavir—Discomfort—Betamethasone—psoriatic arthritis	0.000277	0.00178	CcSEcCtD
Nelfinavir—Discomfort—Dexamethasone—psoriatic arthritis	0.000277	0.00178	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—psoriatic arthritis	0.000277	0.00178	CcSEcCtD
Nelfinavir—Pain—Prednisolone—psoriatic arthritis	0.000276	0.00177	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—psoriatic arthritis	0.000276	0.00177	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—psoriatic arthritis	0.000276	0.00177	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—psoriatic arthritis	0.000274	0.00176	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00027	0.00173	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00027	0.00173	CcSEcCtD
Nelfinavir—Oedema—Betamethasone—psoriatic arthritis	0.000269	0.00173	CcSEcCtD
Nelfinavir—Oedema—Dexamethasone—psoriatic arthritis	0.000269	0.00173	CcSEcCtD
Nelfinavir—Insomnia—Triamcinolone—psoriatic arthritis	0.000268	0.00172	CcSEcCtD
Nelfinavir—Insomnia—Methylprednisolone—psoriatic arthritis	0.000268	0.00172	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000267	0.00171	CcSEcCtD
Nelfinavir—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000266	0.00171	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000266	0.00171	CcSEcCtD
Nelfinavir—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000266	0.00171	CcSEcCtD
Nelfinavir—Anaemia—Prednisone—psoriatic arthritis	0.000266	0.0017	CcSEcCtD
Nelfinavir—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000265	0.0017	CcSEcCtD
Nelfinavir—Agitation—Prednisone—psoriatic arthritis	0.000264	0.00169	CcSEcCtD
Nelfinavir—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000264	0.00169	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000264	0.00169	CcSEcCtD
Nelfinavir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000261	0.00168	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000261	0.00167	CcSEcCtD
Nelfinavir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000261	0.00167	CcSEcCtD
Nelfinavir—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00026	0.00167	CcSEcCtD
Nelfinavir—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00026	0.00167	CcSEcCtD
Nelfinavir—Malaise—Prednisone—psoriatic arthritis	0.000259	0.00166	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—psoriatic arthritis	0.000258	0.00165	CcSEcCtD
Nelfinavir—Anorexia—Dexamethasone—psoriatic arthritis	0.000257	0.00165	CcSEcCtD
Nelfinavir—Anorexia—Betamethasone—psoriatic arthritis	0.000257	0.00165	CcSEcCtD
Nelfinavir—Urticaria—Prednisolone—psoriatic arthritis	0.000256	0.00164	CcSEcCtD
Nelfinavir—Pain—Triamcinolone—psoriatic arthritis	0.000254	0.00163	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—psoriatic arthritis	0.00025	0.00161	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—psoriatic arthritis	0.000249	0.0016	CcSEcCtD
Nelfinavir—Convulsion—Prednisone—psoriatic arthritis	0.000249	0.0016	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000245	0.00157	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000245	0.00157	CcSEcCtD
Nelfinavir—Arthralgia—Prednisone—psoriatic arthritis	0.000245	0.00157	CcSEcCtD
Nelfinavir—Myalgia—Prednisone—psoriatic arthritis	0.000245	0.00157	CcSEcCtD
Nelfinavir—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000245	0.00157	CcSEcCtD
Nelfinavir—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000244	0.00157	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—psoriatic arthritis	0.000244	0.00156	CcSEcCtD
Nelfinavir—Insomnia—Dexamethasone—psoriatic arthritis	0.000244	0.00156	CcSEcCtD
Nelfinavir—Insomnia—Betamethasone—psoriatic arthritis	0.000244	0.00156	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000243	0.00156	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000242	0.00155	CcSEcCtD
Nelfinavir—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000242	0.00155	CcSEcCtD
Nelfinavir—Paraesthesia—Betamethasone—psoriatic arthritis	0.000242	0.00155	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—psoriatic arthritis	0.000242	0.00155	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—psoriatic arthritis	0.00024	0.00154	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—psoriatic arthritis	0.00024	0.00154	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000238	0.00153	CcSEcCtD
Nelfinavir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000237	0.00152	CcSEcCtD
Nelfinavir—Dyspepsia—Betamethasone—psoriatic arthritis	0.000237	0.00152	CcSEcCtD
Nelfinavir—Urticaria—Triamcinolone—psoriatic arthritis	0.000236	0.00151	CcSEcCtD
Nelfinavir—Urticaria—Methylprednisolone—psoriatic arthritis	0.000235	0.00151	CcSEcCtD
Nelfinavir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000235	0.00151	CcSEcCtD
Nelfinavir—Oedema—Prednisone—psoriatic arthritis	0.000234	0.0015	CcSEcCtD
Nelfinavir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000234	0.0015	CcSEcCtD
Nelfinavir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000234	0.0015	CcSEcCtD
Nelfinavir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000234	0.0015	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000232	0.00149	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000232	0.00149	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—psoriatic arthritis	0.000232	0.00149	CcSEcCtD
Nelfinavir—Pain—Betamethasone—psoriatic arthritis	0.00023	0.00148	CcSEcCtD
Nelfinavir—Pain—Dexamethasone—psoriatic arthritis	0.00023	0.00148	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—psoriatic arthritis	0.000228	0.00146	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000227	0.00145	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—psoriatic arthritis	0.000224	0.00143	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000223	0.00143	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—psoriatic arthritis	0.000222	0.00142	CcSEcCtD
Nelfinavir—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000222	0.00142	CcSEcCtD
Nelfinavir—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000222	0.00142	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00022	0.00141	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00022	0.00141	CcSEcCtD
Nelfinavir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000219	0.0014	CcSEcCtD
Nelfinavir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000218	0.0014	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—psoriatic arthritis	0.000217	0.00139	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—psoriatic arthritis	0.000215	0.00138	CcSEcCtD
Nelfinavir—Urticaria—Dexamethasone—psoriatic arthritis	0.000214	0.00137	CcSEcCtD
Nelfinavir—Urticaria—Betamethasone—psoriatic arthritis	0.000214	0.00137	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000214	0.00137	CcSEcCtD
Nelfinavir—Dizziness—Prednisolone—psoriatic arthritis	0.000213	0.00137	CcSEcCtD
Nelfinavir—Asthenia—Triamcinolone—psoriatic arthritis	0.000213	0.00137	CcSEcCtD
Nelfinavir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000213	0.00137	CcSEcCtD
Nelfinavir—Abdominal pain—Betamethasone—psoriatic arthritis	0.000213	0.00137	CcSEcCtD
Nelfinavir—Body temperature increased—Betamethasone—psoriatic arthritis	0.000213	0.00137	CcSEcCtD
Nelfinavir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000213	0.00137	CcSEcCtD
Nelfinavir—Asthenia—Methylprednisolone—psoriatic arthritis	0.000212	0.00136	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—psoriatic arthritis	0.000212	0.00136	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisone—psoriatic arthritis	0.000211	0.00135	CcSEcCtD
Nelfinavir—Pruritus—Triamcinolone—psoriatic arthritis	0.00021	0.00135	CcSEcCtD
Nelfinavir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000209	0.00134	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—psoriatic arthritis	0.000208	0.00133	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—psoriatic arthritis	0.000206	0.00132	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—psoriatic arthritis	0.000204	0.00131	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—psoriatic arthritis	0.000204	0.00131	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—psoriatic arthritis	0.000204	0.00131	CcSEcCtD
Nelfinavir—Rash—Prednisolone—psoriatic arthritis	0.000203	0.00131	CcSEcCtD
Nelfinavir—Dermatitis—Prednisolone—psoriatic arthritis	0.000203	0.0013	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000203	0.0013	CcSEcCtD
Nelfinavir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000203	0.0013	CcSEcCtD
Nelfinavir—Headache—Prednisolone—psoriatic arthritis	0.000202	0.0013	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—psoriatic arthritis	0.000202	0.0013	CcSEcCtD
Nelfinavir—Dizziness—Triamcinolone—psoriatic arthritis	0.000196	0.00126	CcSEcCtD
Nelfinavir—Dizziness—Methylprednisolone—psoriatic arthritis	0.000196	0.00126	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—psoriatic arthritis	0.000193	0.00124	CcSEcCtD
Nelfinavir—Asthenia—Betamethasone—psoriatic arthritis	0.000193	0.00124	CcSEcCtD
Nelfinavir—Asthenia—Dexamethasone—psoriatic arthritis	0.000193	0.00124	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000192	0.00123	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000192	0.00123	CcSEcCtD
Nelfinavir—Nausea—Prednisolone—psoriatic arthritis	0.000192	0.00123	CcSEcCtD
Nelfinavir—Pruritus—Dexamethasone—psoriatic arthritis	0.00019	0.00122	CcSEcCtD
Nelfinavir—Pruritus—Betamethasone—psoriatic arthritis	0.00019	0.00122	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—psoriatic arthritis	0.00019	0.00122	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000189	0.00122	CcSEcCtD
Nelfinavir—Vomiting—Triamcinolone—psoriatic arthritis	0.000189	0.00121	CcSEcCtD
Nelfinavir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000188	0.00121	CcSEcCtD
Nelfinavir—Rash—Triamcinolone—psoriatic arthritis	0.000187	0.0012	CcSEcCtD
Nelfinavir—Dermatitis—Triamcinolone—psoriatic arthritis	0.000187	0.0012	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—psoriatic arthritis	0.000187	0.0012	CcSEcCtD
Nelfinavir—Rash—Methylprednisolone—psoriatic arthritis	0.000187	0.0012	CcSEcCtD
Nelfinavir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000187	0.0012	CcSEcCtD
Nelfinavir—Urticaria—Prednisone—psoriatic arthritis	0.000186	0.0012	CcSEcCtD
Nelfinavir—Headache—Triamcinolone—psoriatic arthritis	0.000186	0.00119	CcSEcCtD
Nelfinavir—Headache—Methylprednisolone—psoriatic arthritis	0.000185	0.00119	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—psoriatic arthritis	0.000185	0.00119	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—psoriatic arthritis	0.000185	0.00119	CcSEcCtD
Nelfinavir—Diarrhoea—Betamethasone—psoriatic arthritis	0.000184	0.00118	CcSEcCtD
Nelfinavir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000184	0.00118	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000179	0.00115	CcSEcCtD
Nelfinavir—Dizziness—Dexamethasone—psoriatic arthritis	0.000178	0.00114	CcSEcCtD
Nelfinavir—Dizziness—Betamethasone—psoriatic arthritis	0.000178	0.00114	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—psoriatic arthritis	0.000177	0.00114	CcSEcCtD
Nelfinavir—Nausea—Triamcinolone—psoriatic arthritis	0.000176	0.00113	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—psoriatic arthritis	0.000176	0.00113	CcSEcCtD
Nelfinavir—Nausea—Methylprednisolone—psoriatic arthritis	0.000176	0.00113	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—psoriatic arthritis	0.000175	0.00112	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—psoriatic arthritis	0.000174	0.00112	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisone—psoriatic arthritis	0.000173	0.00111	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—psoriatic arthritis	0.000172	0.00111	CcSEcCtD
Nelfinavir—Vomiting—Dexamethasone—psoriatic arthritis	0.000171	0.0011	CcSEcCtD
Nelfinavir—Vomiting—Betamethasone—psoriatic arthritis	0.000171	0.0011	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—psoriatic arthritis	0.00017	0.00109	CcSEcCtD
Nelfinavir—Rash—Dexamethasone—psoriatic arthritis	0.00017	0.00109	CcSEcCtD
Nelfinavir—Rash—Betamethasone—psoriatic arthritis	0.00017	0.00109	CcSEcCtD
Nelfinavir—Dermatitis—Betamethasone—psoriatic arthritis	0.00017	0.00109	CcSEcCtD
Nelfinavir—Dermatitis—Dexamethasone—psoriatic arthritis	0.00017	0.00109	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000169	0.00109	CcSEcCtD
Nelfinavir—Headache—Betamethasone—psoriatic arthritis	0.000169	0.00108	CcSEcCtD
Nelfinavir—Headache—Dexamethasone—psoriatic arthritis	0.000169	0.00108	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—psoriatic arthritis	0.000168	0.00108	CcSEcCtD
Nelfinavir—Pain—Methotrexate—psoriatic arthritis	0.000168	0.00108	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—psoriatic arthritis	0.000166	0.00106	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000161	0.00104	CcSEcCtD
Nelfinavir—Diarrhoea—Prednisone—psoriatic arthritis	0.00016	0.00103	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00016	0.00103	CcSEcCtD
Nelfinavir—Nausea—Betamethasone—psoriatic arthritis	0.00016	0.00103	CcSEcCtD
Nelfinavir—Nausea—Dexamethasone—psoriatic arthritis	0.00016	0.00103	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—psoriatic arthritis	0.000156	0.000999	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—psoriatic arthritis	0.000155	0.000995	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000155	0.000994	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000155	0.000994	CcSEcCtD
Nelfinavir—Vomiting—Prednisone—psoriatic arthritis	0.000149	0.000957	CcSEcCtD
Nelfinavir—Rash—Prednisone—psoriatic arthritis	0.000148	0.000949	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—psoriatic arthritis	0.000148	0.000948	CcSEcCtD
Nelfinavir—Headache—Prednisone—psoriatic arthritis	0.000147	0.000942	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000144	0.000926	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—psoriatic arthritis	0.000141	0.000902	CcSEcCtD
Nelfinavir—Nausea—Prednisone—psoriatic arthritis	0.000139	0.000894	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—psoriatic arthritis	0.000139	0.00089	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000134	0.00086	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—psoriatic arthritis	0.00013	0.000831	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—psoriatic arthritis	0.000125	0.000799	CcSEcCtD
Nelfinavir—Rash—Methotrexate—psoriatic arthritis	0.000124	0.000793	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—psoriatic arthritis	0.000123	0.000792	CcSEcCtD
Nelfinavir—Headache—Methotrexate—psoriatic arthritis	0.000123	0.000788	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—psoriatic arthritis	0.000116	0.000747	CcSEcCtD
